Selected research
Industry Growth & Trends
Global One-Stop Service for Gene-Edited Cell Lines Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global One-Stop Service for Gene-Edited Cell Lines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for One-Stop Service for Gene-Edited Cell Lines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for One-Stop Service for Gene-Edited Cell Lines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for One-Stop Service for Gene-Edited Cell Lines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the One-Stop Service for Gene-Edited Cell Lines market include Amsbio, Charles River Laboratories, Creative Biogene, Cytiva, Eurofins Genomics, Evotec, GenScript, Horizon Discovery and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global One-Stop Service for Gene-Edited Cell Lines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The One-Stop Service for Gene-Edited Cell Lines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global One-Stop Service for Gene-Edited Cell Lines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to One-Stop Service for Gene-Edited Cell Lines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global One-Stop Service for Gene-Edited Cell Lines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
One-Stop Service for Gene-Edited Cell Lines Market by Company
Amsbio
Charles River Laboratories
Creative Biogene
Cytiva
Eurofins Genomics
Evotec
GenScript
Horizon Discovery
Lonza
ViroCell Biologics
Sartorius
Synbio Technologies
Takara Bio
Thermo Fisher Scientific
BoyaLife
HEMABIO
BGI Genomics
GenScript Biotech
Shanghai Model Organisms
Vazyme
One-Stop Service for Gene-Edited Cell Lines Segment by Type
Gene Knockout Service
Gene Knockin Service
One-Stop Service for Gene-Edited Cell Lines Segment by Application
Universities and Research Institutions
Biopharmaceutical Industry
Others
One-Stop Service for Gene-Edited Cell Lines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Service for Gene-Edited Cell Lines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of One-Stop Service for Gene-Edited Cell Lines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Service for Gene-Edited Cell Lines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of One-Stop Service for Gene-Edited Cell Lines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Knockout Service
- Gene Knockin Service
Applications
- Universities and Research Institutions
- Biopharmaceutical Industry
- Others
Companies covered
- Amsbio
- Charles River Laboratories
- Creative Biogene
- Cytiva
- Eurofins Genomics
- Evotec
- GenScript
- Horizon Discovery
- Lonza
- ViroCell Biologics
- Sartorius
- Synbio Technologies
- Takara Bio
- Thermo Fisher Scientific
- BoyaLife
- HEMABIO
- BGI Genomics
- GenScript Biotech
- Shanghai Model Organisms
- Vazyme
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global One-Stop Service for Gene-Edited Cell Lines Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region (2021-2032)
- 1.4.1 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region (2021-2026)
- 1.4.2 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region (2027-2032)
- 1.5 Key Regions One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
- 1.5.1 North America One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (2021-2032)
- 1.5.2 Europe One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (2021-2032)
- 1.5.4 South America One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (2021-2032)
2 One-Stop Service for Gene-Edited Cell Lines Market by Type
- 2.1 Type Introduction
- 2.1.1 Gene Knockout Service
- 2.1.2 Gene Knockin Service
- 2.2 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Type
- 2.2.1 Global One-Stop Service for Gene-Edited Cell Lines Market Size Overview by Type (2021-2032)
- 2.2.2 Global One-Stop Service for Gene-Edited Cell Lines Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global One-Stop Service for Gene-Edited Cell Lines Market Size Forecasted by Type (2027-2032)
- 2.3 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Regions
- 2.3.1 North America One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Type (2021-2026)
3 One-Stop Service for Gene-Edited Cell Lines Market by Application
- 3.1 Type Introduction
- 3.1.1 Universities and Research Institutions
- 3.1.2 Biopharmaceutical Industry
- 3.1.3 Others
- 3.2 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Application
- 3.2.1 Global One-Stop Service for Gene-Edited Cell Lines Market Size Overview by Application (2021-2032)
- 3.2.2 Global One-Stop Service for Gene-Edited Cell Lines Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global One-Stop Service for Gene-Edited Cell Lines Market Size Forecasted by Application (2027-2032)
- 3.3 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Regions
- 3.3.1 North America One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa One-Stop Service for Gene-Edited Cell Lines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 One-Stop Service for Gene-Edited Cell Lines Industry Trends
- 4.2 One-Stop Service for Gene-Edited Cell Lines Industry Drivers
- 4.3 One-Stop Service for Gene-Edited Cell Lines Industry Opportunities and Challenges
- 4.4 One-Stop Service for Gene-Edited Cell Lines Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by One-Stop Service for Gene-Edited Cell Lines Revenue (2021-2026)
- 5.2 Global One-Stop Service for Gene-Edited Cell Lines Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global One-Stop Service for Gene-Edited Cell Lines Key Company Headquarters & Area Served
- 5.4 Global One-Stop Service for Gene-Edited Cell Lines Company, Product Type & Application
- 5.5 Global One-Stop Service for Gene-Edited Cell Lines Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global One-Stop Service for Gene-Edited Cell Lines Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 One-Stop Service for Gene-Edited Cell Lines Players Market Share by Revenue in 2025
- 5.6.3 2025 One-Stop Service for Gene-Edited Cell Lines Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Amsbio
- 6.1.1 Amsbio Company Information
- 6.1.2 Amsbio Business Overview
- 6.1.3 Amsbio One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Amsbio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.1.5 Amsbio Recent Developments
- 6.2 Charles River Laboratories
- 6.2.1 Charles River Laboratories Company Information
- 6.2.2 Charles River Laboratories Business Overview
- 6.2.3 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.2.5 Charles River Laboratories Recent Developments
- 6.3 Creative Biogene
- 6.3.1 Creative Biogene Company Information
- 6.3.2 Creative Biogene Business Overview
- 6.3.3 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.3.5 Creative Biogene Recent Developments
- 6.4 Cytiva
- 6.4.1 Cytiva Company Information
- 6.4.2 Cytiva Business Overview
- 6.4.3 Cytiva One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Cytiva One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.4.5 Cytiva Recent Developments
- 6.5 Eurofins Genomics
- 6.5.1 Eurofins Genomics Company Information
- 6.5.2 Eurofins Genomics Business Overview
- 6.5.3 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.5.5 Eurofins Genomics Recent Developments
- 6.6 Evotec
- 6.6.1 Evotec Company Information
- 6.6.2 Evotec Business Overview
- 6.6.3 Evotec One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Evotec One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.6.5 Evotec Recent Developments
- 6.7 GenScript
- 6.7.1 GenScript Company Information
- 6.7.2 GenScript Business Overview
- 6.7.3 GenScript One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GenScript One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.7.5 GenScript Recent Developments
- 6.8 Horizon Discovery
- 6.8.1 Horizon Discovery Company Information
- 6.8.2 Horizon Discovery Business Overview
- 6.8.3 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.8.5 Horizon Discovery Recent Developments
- 6.9 Lonza
- 6.9.1 Lonza Company Information
- 6.9.2 Lonza Business Overview
- 6.9.3 Lonza One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Lonza One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.9.5 Lonza Recent Developments
- 6.10 ViroCell Biologics
- 6.10.1 ViroCell Biologics Company Information
- 6.10.2 ViroCell Biologics Business Overview
- 6.10.3 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.10.5 ViroCell Biologics Recent Developments
- 6.11 Sartorius
- 6.11.1 Sartorius Company Information
- 6.11.2 Sartorius Business Overview
- 6.11.3 Sartorius One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sartorius One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.11.5 Sartorius Recent Developments
- 6.12 Synbio Technologies
- 6.12.1 Synbio Technologies Company Information
- 6.12.2 Synbio Technologies Business Overview
- 6.12.3 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.12.5 Synbio Technologies Recent Developments
- 6.13 Takara Bio
- 6.13.1 Takara Bio Company Information
- 6.13.2 Takara Bio Business Overview
- 6.13.3 Takara Bio One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Takara Bio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.13.5 Takara Bio Recent Developments
- 6.14 Thermo Fisher Scientific
- 6.14.1 Thermo Fisher Scientific Company Information
- 6.14.2 Thermo Fisher Scientific Business Overview
- 6.14.3 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.14.5 Thermo Fisher Scientific Recent Developments
- 6.15 BoyaLife
- 6.15.1 BoyaLife Company Information
- 6.15.2 BoyaLife Business Overview
- 6.15.3 BoyaLife One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 BoyaLife One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.15.5 BoyaLife Recent Developments
- 6.16 HEMABIO
- 6.16.1 HEMABIO Company Information
- 6.16.2 HEMABIO Business Overview
- 6.16.3 HEMABIO One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 HEMABIO One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.16.5 HEMABIO Recent Developments
- 6.17 BGI Genomics
- 6.17.1 BGI Genomics Company Information
- 6.17.2 BGI Genomics Business Overview
- 6.17.3 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.17.5 BGI Genomics Recent Developments
- 6.18 GenScript Biotech
- 6.18.1 GenScript Biotech Company Information
- 6.18.2 GenScript Biotech Business Overview
- 6.18.3 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.18.5 GenScript Biotech Recent Developments
- 6.19 Shanghai Model Organisms
- 6.19.1 Shanghai Model Organisms Company Information
- 6.19.2 Shanghai Model Organisms Business Overview
- 6.19.3 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.19.5 Shanghai Model Organisms Recent Developments
- 6.20 Vazyme
- 6.20.1 Vazyme Company Information
- 6.20.2 Vazyme Business Overview
- 6.20.3 Vazyme One-Stop Service for Gene-Edited Cell Lines Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Vazyme One-Stop Service for Gene-Edited Cell Lines Product Portfolio
- 6.20.5 Vazyme Recent Developments
7 North America
- 7.1 North America One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 7.3 North America One-Stop Service for Gene-Edited Cell Lines Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 8.3 Europe One-Stop Service for Gene-Edited Cell Lines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 9.3 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 10.3 South America One-Stop Service for Gene-Edited Cell Lines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
- 11.3 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst